For the Inventor, By the Inventor

Enter assignee name

Shanghai, China

Impact Therapeutics (shanghai), Inc

USPTO Granted Patents = 5

Forward Citations = 0

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

Ye Edward Tian (5 out of 14 patents)

Xiaozhu Wang (4 out of 8 patents)

Sui Xiong Cai (3 out of 8 patents)

4. Suixiong Cai (2 out of 8 patents)

5. Zhiqiang Dong (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12492197 - 3,5-disubstituted pyrazole compounds as kinase inhibitors and uses thereof (2025-12-09),

2. 12479848 - Substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and the use thereof (2025-11-25),

3. 11547703 - Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof (2023-01-10),

4. 11345711 - 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones (2022-05-31),

5. 11345710 - Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and the use thereof (2022-05-31),

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#393 in Shanghai

#4,587 in China

Shanghai, China

Impact Therapeutics (shanghai), Inc

Forward Citations = 0

5 inventors:

Ye Edward Tian (5 out of 14 patents)

Xiaozhu Wang (4 out of 8 patents)

Sui Xiong Cai (3 out of 8 patents)

4. Suixiong Cai (2 out of 8 patents)

5. Zhiqiang Dong (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

Loading…